alphaveNIACL₹197.14

The New India Assurance Company Ltd.

Annual Quarterly₹ CrorePeersGICRE ICICIGI STARHEALTH NAM-INDIA SUNDARMFIN ICICIPRULI HDBFS CRISIL

View

In ₹ Crore except Per Share 12 Months Ending	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue Detail — as filed
+ Operating Income	11,008.7	11,080.5	12,339.7	11,428.6	11,840.1	11,300.1
+ Income from Investments (net)	1,656.3	1,656.5	2,884.3	1,657.7	1,818.3	1,552.8
Expense Detail — as filed
+ Employee Remuneration & Welfare	263.5	666.4	1,514.6	1,308.6	997.6	796.3
+ Commission (net)	1,094.5	933.5	922.0	1,048.2	961.7	954.0
+ Commission & Brokerage (net)	1,094.5	933.5	922.0	1,048.2	961.7	954.0
+ Provision — Diminution in Investments	34.8	11.2	16.6	16.6	18.5	17.1
+ Provision — Doubtful Debts & Write-offs	-92.0	1.0	0.4	0.3	2.4	-0.4
+ Non-operating Expense	725.4	351.4	307.0	351.2	672.2	15.1
+ Non-operating Provision — Diminution in Investments	14.3	4.4	6.4	6.4	7.0	6.5
+ Non-operating Provision — Doubtful Debts	712.9	186.3	0.2	0.1	0.9	-0.2
Profit Build-up — Alternate / Pre-Ind-AS Tags
Profit before Extraordinary Items	502.4	391.1	23.4	372.2	446.1	-178.7
Profit / (Loss) before Tax — alt tag	502.4	391.1	23.4	372.2	446.1	-178.7
+ Provision for Tax	180.8	-1.3	3.3	-4.7	-118.0	65.3
Profit / (Loss) after Tax	321.6	392.4	20.1	376.9	564.2	-243.9
Profit Carried to Balance Sheet	358.6	400.3	54.1	380.0	577.9	-242.7
Per Share — as-filed variants
Basic & Diluted EPS before Extraordinary (not annualised)	2.18	2.43	0.33	2.31	3.51	-1.47
Basic & Diluted EPS after Extraordinary (not annualised)	2.18	2.43	0.33	2.31	3.51	-1.47
Appropriations & Transfers
+ Transfer to Profit & Loss Account	495.5	-97.8	-671.9	-82.9	-12.5	-789.7
Reserves & Surplus excl. Revaluation Reserve	21,932.1	22,373.4	22,232.2	22,699.0	23,802.1	23,654.1
+ Final Dividend	0.0	0.0	0.0	0.0	0.0	0.0
Insurance — Revenue Account (Policyholders')
Premium Earned	9,352.5	9,424.0	9,455.4	9,771.0	10,021.8	9,747.3
+ Gross Premiums Written	11,528.2	13,445.5	10,644.7	11,762.8	11,727.0	13,835.1
+ Net Premium Written	9,800.2	10,902.3	8,869.4	9,716.7	10,062.6	11,297.9
+ Operating Expenses — Insurance Business	587.6	863.8	1,842.7	1,605.5	1,316.6	1,099.9
+ Non-operating Expenses — Non-insurance	-1.8	160.8	300.4	344.7	664.2	8.8
+ Claims Paid	8,637.9	8,286.1	8,772.1	8,770.2	8,817.6	9,369.7
+ Incurred Claims	8,831.2	9,381.0	10,246.9	8,858.0	9,574.2	10,035.9
+ Change in Outstanding Claims	193.3	1,094.9	1,474.8	87.8	756.6	666.2
Insurance — Shareholders' Account
+ Income — Shareholders' Account	1,227.8	742.5	330.3	723.4	1,118.3	-163.6
+ Shareholders' Investment Income	655.5	638.5	1,110.0	640.6	703.8	599.6
+ Transfer from Policyholders' Fund	495.5	-97.8	-671.9	-82.9	-12.5	-789.7
With Unrealised Gains	0.0	0.0	0.0	0.0	0.0	0.0
Without Unrealised Gains	0.0	0.0	0.1	0.0	0.0	0.0
Insurance — Fund NPAs
+ Gross NPAs — Policyholders' Fund	150.6	150.6	150.6	150.6	150.3	146.3
Insurance — IRDAI Ratios (as filed, not percentages)
Solvency Ratio	0.02	0.02	0.02	0.02	0.02	0.02
Combined Ratio	1.12	1.16	1.40	1.18	1.18	1.21
Incurred Claim Ratio	0.94	1.00	1.08	0.91	0.96	1.03
Net Retention Ratio	0.85	0.81	0.83	0.83	0.86	0.82
Expenses of Management Ratio	0.15	0.15	0.28	0.17	0.21	0.17
Regulatory Disclosures — filed alongside, not part of the P&L
Investor Complaints — Received	0.00	0.00	3.00	1.00	0.00	0.00
Investor Complaints — Disposed	0.00	0.00	3.00	1.00	0.00	0.00
Other Filed Concepts — mapped but not yet placed in the schedule
Operating Expenses	10,513.3	11,178.3	13,011.6	11,511.6	11,852.5	12,089.8
Other Operating Expenses	324.0	197.4	328.1	296.9	319.0	303.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.